about
Effects of Interferons and Viruses on MetabolismFunctional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro.Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.A New Immunomodulatory Role for Peroxisomes in Macrophages Activated by the TLR4 Ligand Lipopolysaccharide.mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expressionQuantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Restoration of renal function does not correct impairment of uremic HDL propertiesSerum amyloid A in uremic HDL promotes inflammationApplied immuno-epidemiological research: an approach for integrating existing knowledge into the statistical analysis of multiple immune markersThe multiple functions of Tamm-Horsfall protein in human health and disease: a mystery clears up.Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycinUncovering host defences in the urinary tract: cathelicidin and beyond.Current concepts of molecular defence mechanisms operative during urinary tract infection.The multiple facets of mTOR in immunity.The multifunctional role of mTOR in innate immunity: implications for transplant immunity.Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.The versatility of HDL: a crucial anti-inflammatory regulator.Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.Immune responses of macrophages and dendritic cells regulated by mTOR signalling.Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms.Regulation of innate immune cell function by mTOR.mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function.PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.mTORC1 and mTORC2 as regulators of cell metabolism in immunity.Rapid isolation of nuclei from living immune cells by a single centrifugation through a multifunctional lysis gradient.Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein.Antithymocyte globulin impairs T-cell/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation.HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.Sirolimus and kidney transplantation: unraveling an inflammatory affair.A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.T helper cell differentiation: understanding the needs of hierarchy.Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates.Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity.The anti-inflammatory potency of dexamethasone is determined by the route of application in vivo.CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.The TSC-mTOR signaling pathway regulates the innate inflammatory response.Biological action of rapamycin in renal transplantation.
P50
Q28353943-4644174D-87D1-418B-A16E-AB32201A5457Q30967126-5CF2B6EB-A7C3-4E58-A414-6CDE80B1ECFAQ33714856-3B613638-92F1-45E2-B77A-E6B228AD176BQ34047964-986D1868-79E4-47EF-91DF-49F4C88820DCQ34183531-B0C5EC9E-B760-43BD-ACF8-A98EF95FA1EFQ35051225-0AFCFBAF-79FD-4663-A355-0735BAA0C273Q35124223-78FC0675-8169-490C-A859-7BE0E257588BQ35917487-7A361BE5-547B-48DC-86D1-3BC1B59B23F2Q36024392-A6F1530B-24BE-4542-99C7-27B8AC51CDDAQ36179516-D9AAB72F-1081-437B-B66F-698696AFFFF5Q36383953-6BB3297C-7E67-421E-BA75-530E9BB5CAA6Q36586138-DD8A7BA9-D689-4DBB-8EE3-59005590111CQ36621096-4013F64B-BDAD-4C3E-B97F-A075ADC43D63Q37282760-3DF6C261-50FE-49C4-A3F2-D8F1BF2EB12BQ37441725-C12A5264-3E77-4B1B-920B-DE19BBE65D8DQ37605193-4813462E-A6EF-4416-A5A0-5A302BB407F3Q37660352-779431ED-92AA-4162-BFED-614977CE95B8Q37778848-05E6653C-1EAD-426A-94A4-C02C6EF008F9Q38095581-10C1C0B4-F100-4CBE-930A-774209E467EEQ38122223-001EE916-8086-4F9A-B2EE-E84C1CF21325Q38187149-B17FD6A8-A650-4D5F-87FD-021F20D77141Q38592317-B52A9F19-4B7E-4340-9450-92402949B882Q38951050-2A69C49B-6DAD-4D5A-84DD-AE5974E55DC6Q39259618-291B6B3B-4A34-4C6A-96AE-D551D3002500Q39363666-6FB126A5-65F1-405B-B548-87463D709377Q39479953-333FABBA-C998-48A8-A9B8-709A64C94F32Q39779359-6A13A62C-BEFF-4B68-AD6C-7CE3EA601C24Q40069493-272839B1-F85B-49D0-8660-964FDBD32F50Q40107879-85AD7471-7E01-46DC-80FC-222E064AA233Q40587729-F5ED29B0-ADFD-46E0-B445-010A0644A455Q42357002-C5F30F91-2E48-4D62-8494-09CF7106A2B9Q42790834-A28B2570-D5B9-4EFE-86C1-525250EC369BQ42921848-494F1BA3-0113-45B9-9AD5-8C3BC120C06CQ42974017-BFE883E0-D4D5-46C0-9DF1-CBD849A7A30BQ43119566-92BDBF7D-D403-43AE-9C42-2FDE3206D30AQ43195588-D56E6E69-1D76-448B-832D-D301E0EF6E01Q43198786-878355AE-F244-4A87-B6D7-EE2659D6C5C9Q43583466-01E164AD-5003-4CE6-9C87-D0FF7BEF7D39Q46321173-052C36C6-16A3-4840-A3E1-345B43A22F16Q46737575-CEC82FAA-069F-4629-8037-75CC269911C7
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Weichhart
@ast
Thomas Weichhart
@en
Thomas Weichhart
@es
Thomas Weichhart
@nl
Thomas Weichhart
@sl
type
label
Thomas Weichhart
@ast
Thomas Weichhart
@en
Thomas Weichhart
@es
Thomas Weichhart
@nl
Thomas Weichhart
@sl
prefLabel
Thomas Weichhart
@ast
Thomas Weichhart
@en
Thomas Weichhart
@es
Thomas Weichhart
@nl
Thomas Weichhart
@sl
P1006
P214
P244
P1006
P1053
J-3531-2014
P106
P1153
8568042800
P21
P213
0000 0003 6360 8892
P214
P244
nb2012001563
P2798
P31
P3829
P496
0000-0002-4349-0797
P735
P7859
lccn-nb2012001563